Programme
Thursday, September 12, 2013
10:00 – 18:00 Registration and poster mounting
11:00 – 13:00 Guided tour to Sümeg Castle with lunch (optional)
17:00 Introductory Remarks
Plenary Lecture
17:15 Michal Toborek
(University of Miami, USA)
Targeting the gut-brain axis for modulation of brain metastasis formation
18:00–19:00 SESSION I.: BLOOD-BRAIN BARRIER MODELS.
NEW DEVELOPMENTS
Chair: Winfried Neuhaus
18:00 N Joan Abbott
(King’s College London, UK)
An in vitro ‘double-decker’ blood-brain barrier (DD-BBB) co-culture
model: combining permeability assay and functional assessment
of glioblastoma treatment
18:20 Marie-Pierre Dehouck
(University Lille Nord de France, U. Artois, France)
A stable and reproducible human blood-brain barrier model derived from stem cells
18:40 Pierre-Olivier Couraud
(Institut Cochin, Paris, France)
Pharmacological studies and pathogen interactions
with human brain endothelial cells in vitro
under flow
19:00 Welcome Reception
Friday, September 13, 2013
9:00–12:00 SESSION II.: MOLECULAR MECHANISMS OF THE REGULATION Chairs: Ingolf Blasig, Walter Hunziker
|
9:00 Anuska Andjelkovic
9:20 Walter Hunziker
9:40 Tetsuya Terasaki
10:00 Ingolf Blasig
10:20 Coffee break
11:00 Jimmi Cording
11:20 Anja Feldner
11:40 Daniela Virgintino CXCL12 secretion by radial glia (rg) cells is involved in glio-vascular 12:00 Lunch
13:40–15:40 SESSION III.: TRANSPORT PROCESSES OF THE 13:40 Birger Brodin
14:00 David Male Delivery of glucose-coated gold nanoparticles to astrocytes by transfer
14:20 Svetlana Drndarski
14:40 Brankatschk Marko Lipoprotein particles cross the BBB and regulate insulin signaling in drosophila
15:00 Christian Staat C1C2, a claudin-derived peptide to enhance drug delivery - mode of action 15:20 Lajos Szente
15:40 Coffee Break
16:00 – 18:00 Poster session I P1 Sonia Al-qadi (University of Copenhagen, Denmark) P2 Annette Burkhart (Aalborg University, Denmark) P3 Louiza B. Thomsen (Aalborg University, Denmark) P4 Christian Tscheik (Leibniz-Institute of Molecular Pharmacology, Berlin,Germany) P5 Daniela E. Eigenmann (University of Basel, Switzerland) P6 András Kincses (Biological Research Centre, HAS, Szeged, Hungary) P7 Antje Appelt-Menzel (University Clinic Würzburg, Germany) P8 Andrea Harrer (Paracelsus Medical University, Salzburg, Austria) P9 Nora Gehne (Leibniz-Institute of Molecular Pharmacology, Berlin, Germany) P10 Stefanie E. Herberich (German Cancer Research Center, Heidelberg, Germany) P11 Petra Hülper (University of Göttingen, Germany) P12 Alexandra Bocsik (Biological Research Centre, HAS, Szeged, Hungary) P13 Lars Winkler (Leibniz-Institute of Molecular Pharmacology, Berlin, Germany) P14 Nemanja Milicevic (Leibniz-Institute of Molecular Pharmacology, Berlin, Germany) P15 Mareen Lüthen (Free University Berlin, Germany) P16 Rosel Blasig (Leibniz-Institute of Molecular Pharmacology, Berlin, Germany) P17 Shalmali Patkar (University of Zurich, Switzerland) P18 Victoria Makrides (University of Zurich, Switzerland) P19 Elena Dolgodilina (University of Zurich, Switzerland) P20 Steffen Strock (University Medical Center Mainz, Germany) P21 Reiner F. Haseloff (Leibniz-Institute of Molecular Pharmacology, Berlin, Germany) P22 Hans-Christian Bauer (Paracelsus Medical University, Salzburg, Austria) P23 Aleksandra Szczepkowska (Institute of Animal Reproduction and P24 Janina Skipor (Institute of Animal Reproduction and Food Research, P25 Ádám Nyúl-Tóth (Biological Research Centre, HAS, Szeged, Hungary) P26 Imola Wilhelm (Biological Research Centre, HAS, Szeged, Hungary)
19:00 Wine tasting and dinner
|
Saturday, September 14, 2013
9:00–12:00 SESSION IV.: THE BBB IN CNS DISORDERS I.
Chairs: N Joan Abbott, Alon Friedman
9:00 Alon Friedman
(Ben-Gurion University of the Negev, Israel)
Measuring brain vascular permeability in clinical
practice: why, when and how
9:20 Shilpa Buch
(University of Nebraska, Omaha, USA)
HIV Tat-mediated induction of platelet-derived
growth factor in pericytes: implications for pericyte migration
9:40 Ibolya András
(University of Miami, USA)
HIV-1 induced nuclear amyloid beta uptake is
regulated by the Smad signaling pathway in brain endothelial cells
10:00 Victor Castro
(University of Miami, USA)
Occludin controls metabolic integrative pathways and modulates HIV-infection
10:20 Coffee break
11:00 Fabien Gosselet
(University Lille Nord de France, U. Artois, France)
Oxysterols, liver X receptors (Lxrs) & Alzheimer’s
disease: focus at the blood-brain barrier (BBB) level
11:20 Claus Pietrzik
(Institute of Pathobiochemistry, University Medical Center Mainz, Germany)
Nanoparticulate flurbiprofen affects Aβ42 generation in an in vitro blood-brain
barrier model
11:40 Sandra Orozco Suárez
(Instituto Mexicano del Seguro Social, Mexico)
Structural alterations in brain barrier components in
Rasmussen encephalitis
12:00 Lunch
13:40– 15:20 SESSION V.: THE BBB IN CNS DISORDERS II.
Chairs: Shilpa Buch, Roméo Cecchelli
13:40 Ágnes Kittel
(Institute of Experimental Medicine, HAS, Budapest, Hungary)
Ultrastructural changes of blood-brain barrier in l- ornithine induced pancreatitis
14:00 Fruzsina Walter
(Biological Research Centre, HAS, Szeged, Hungary)
Effects of l-ornithine on cultured primary brain endothelial cells
14:20 Colin Willis
(University of New England, Biddeford, USA
Integrin receptor mediated oxidative stress modulates blood-brain barrier integrity
14:40 Zoran Redzic
(Kuwait University, Kuwait)
Differential effects of paracrine factors on the survival of cells
of the neurovascular unit during oxygen glucose deprivation
15:00 Sabrina Engelhardt
(University of Zurich, Switzerland)
The BBB under hypoxic attack – a comparative study on cell-specific responses
15:20 Coffee break
15:40 – 17:20 Poster session II
P27 Csilla Fazakas (Biological Research Centre, HAS, Szeged, Hungary)
Role of rho-kinases (ROCK) in melanoma brain metastasis formation
P28 Judit Molnár (Biological Research Centre, HAS, Hungary)
Signal transduction pathways involved in the transmigration of melanoma
cells through the blood-brain barrier
P29 János Haskó (Biological Research Centre, HAS, Hungary)
Role of cannabinoid receptor 2 in the formation of brain metastases of melanoma
P30 Francisca Fernandez-Valverde (Instituto Nacional de Neurología y
Neurocirugía, Mexico City, Mexico)
Ultrastructural characteristics of blood–brain barrier in cerebral lymphoma metastases
P31 Mehmet Kaya (Istanbul University, Turkey)
Exogenous beta hydroxybutyrate alters blood-brain barrier integrity in normal rats
P32 Anne Winkler (University of Göttingen, Germany)
Early breakdown of the blood-brain barrier in a model of neuromyelitis optica
P33 András Harazin (Biological Research Centre, HAS, Szeged, Hungary)
Blood-brain barrier opening and gene expression of cationic amino
acid transporter-1 in brain microvessels in l-ornithine induced acute pancreatitis in rats
P34 Andrea E. Tóth (Biological Research Centre, HAS, Szeged, Hungary)
Edaravone protects against acute carbonyl stress in human brain endothelial cells
P35 Winfried Neuhaus (University of Vienna, Austria)
Novel therapeutical in-vitro approaches for stroke treatment: The role of the
tPA/PAI-1 axis at the blood-brain barrier
P36 Masahiro Nishibori(Okayama University, Japan)
Protection of BBB disruption in ischemic and traumatic injuries by
anti-HMGB1 monoclonal antibody
P37 Shuji Fukuda (Nagasaki University, Japan)
Cilostazol improves the BBB barrier functions against AGEs-related ischemic damage via TGF-β signaling
P38 Yoichi Morofuji (Nagasaki University, Japan)
Pitavastatin ameliorates lipopolysaccharide-induced dysfunction of blood-brain barrier
P39 Dong Hyun Jo (Seoul National University, Republic of Korea)
Therapeutic potential of metal nanoparticles on pathologic angiogenesis in the retina
P40 Sabrina Meister (University Medical Center Mainz, Germany)
Impaired BBB integrity of ALS spinal cord derived endothelial cells
P41 Péter Sipos (University of Szeged, Hungary)
Physicochemical characterization of nanosized vesicular carriers for drug delivery to brain
P42 Lóránd Kiss (Biological Research Centre, HAS, Szeged, Hungary)
Nanovesicles for drug delivery across blood-brain barrier: a cell culture study
P43 Ildikó Bácskay (University of Debrecen, Hungary)
Evaluation of the relations between structure and cytotoxic effects and
paracellular transport enhancer effect of different α-cyclodextrin derivatives
P44 Piotr Ruszkowski (Poznan University, Poland)
In vitro studies on lamotrigine blood-brain barrier permeability and
its anticancer activity against glioma cancer cells
P45 Sofia Gustafsson (Uppsala University, Sweden)
Combined microPET imaging and microdialysis sampling in a study
of oxycodone active uptake in rat brain
P46 Annika Lindqvist (Uppsala University, Sweden)
Mechanistic evaluation of the increaised brain delivery of the opioid peptide
P47 Lorena Reyes Santos (Instituto Nacional de Neurología y Neurocirugía, Mexico)
Effect of systemic tuberculosis in the neuronal and blood-brain barrier alterations in a murine experimental model.
P48 Petra Sántha (Biological Research Centre, HAS, Szeged, Hungary)
Stress induced alterations in the morphology of the neurovascular unit
P49 Francisca Tristan Agundis (Hospital Psiquiátrico Fray Bernardino
Álvarez, Mexico City, Mexico)
Morphological impairment of blood-brain barrier in Alzheimer’s disease
P50 Inês Sá-Pereira (University of Oxford, UK)
Neurodevelopmental response to intracerebral inflammation
P51 Juana Villeda-Hernández (Hospital de especialidades del Centro
Médico Nacional, Mexico City, Mexico)
Structural and ultrastructural characteristics in blood brain barrier in
neocortex of patients with refractory epilepsy
P52 Udi Vazana (Ben-Gurion Univeristy of the Negev, Israel)
Low-frequency transcranial magnetic stimulation enhances blood-brain barrier permeability: a combined animal and human study
P53 Colin Willis (University of New England, Biddeford, USA)
Migraine medication induces AKT phosphorylation and modulates blood-brain
barrier integrity
P54 Andrej Kovac (Institute of Neuroimmunology, Slovak Academy of Sciences, Slovakia)
OspA-CD40 interaction is important for translocation of neuroinvasive Borrelia across the blood-brain barrier
18:00 Historical Tournaments and Medieval Dinner
Sunday, September 15, 2013
Breakfast and check out
Dismounting posters
Shuttle buses to Liszt Ferenc International Airport, Budapest
Date of Congress:
September 12th-14th2013
Preferential Registration Deadline:
July 31th 2013
Abstract submission Deadline:
July 31th 2013
Hotel Kapitány**** Wellness and Conference
H-8330 Sümeg
Tóth Tivadar str. 19.
Webpage: http://www.hotelkapitany.hu/
If you wish you support the Conference as a sponsor please contact: